The Safety and Feasibility of tDCS Combined With Conservative Treatment for Cervicogenic Headaches

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
Annually, up to 150,000 individuals are affected by cervicogenic headaches (CGH) in Canada with many of these cases being chronic. Current treatments for CGH are limited in efficacy and durability - indicating a dire need for novel interventions in this population. Transcranial direct current stimulation (tDCS) and physiotherapy have a high degree of safety and have been studied as interventions for many other chronic pain conditions and headache disorders. We propose to study the feasibility and safety of tDCS alongside physiotherapy for CGH further in a randomized sham controlled trial.
Epistemonikos ID: cd644a73bbce56b9049643790037d105a9bd8097
First added on: May 14, 2024